Lynx1 Capital Management

Lynx1 Capital Management as of June 30, 2022

Portfolio Holdings for Lynx1 Capital Management

Lynx1 Capital Management holds 12 positions in its portfolio as reported in the June 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bellus Health Com New 22.3 $26M 2.8M 9.24
Merus N V (MRUS) 19.3 $23M 1.0M 22.64
Kinnate Biopharma 18.0 $21M 1.7M 12.61
Alpine Immune Sciences 14.0 $16M 1.9M 8.51
Cymabay Therapeutics 6.5 $7.6M 2.6M 2.95
Pardes Biosciences 5.7 $6.7M 2.2M 3.07
Pieris Pharmaceuticals 5.1 $6.0M 3.2M 1.87
Immunic (IMUX) 3.3 $3.8M 1.1M 3.47
Aerovate Therapeutics (AVTE) 2.6 $3.0M 192k 15.63
Theseus Pharmaceuticals 2.4 $2.8M 505k 5.53
Passage Bio (PASG) 0.8 $995k 421k 2.36
Otonomy 0.1 $62k 30k 2.07